Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 249

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 249
---
 giving effect to such exercise. The holders of Pre-FundedWarrants may increase or decrease such percentages not in excess of 19.99% by providing at least 61 days’ prior notice to us. The closing of the PIPE Financing is expected to occur on a date that is no later than five business days from the date on which stockholder approval is obtained. Registration Rights Agreement At the closing of the PIPE Financing, in connection with the Subscription Agreement, we intend to enter into a Registration Rights Agreement with the PIPE Investors. Pursuant to the Registration Rights Agreement, we will prepare and file a resale registration statement with the SEC on or prior to the later of (i) thirty (30) days following the closing of the PIPE Financing and (ii) five (5) business days following the filing of our audited financial statements for the year ended December 31, 2024. We will use its commercially reasonable efforts to cause this registration statement to be declared effective by the SEC within 60 calendar days of the closing of the PIPE Financing (or within 90 calendar days if the SEC reviews the registration statement), subject to acceleration under certain circumstances. We will also agree, among other things, to indemnify each participating holder, their officers, directors, members, employees, and agents, successors and assigns, and each other person, if any, who controls such participating holder within the meaning of the Securities Act of 1933, as amended (the “Securities Act”), under the registration statement from certain losses, claims, damages, liabilities and expenses incident to our obligations under the Registration Rights Agreement. Participation in the PIPE Financing by Aadi’s Directors, Executive Officers and 5% Holders The PIPE Investors include entities that are related to Casey Castelein, M.D., Anupam Dalal, M.D., Behzad Aghazadeh, Ph.D. and Baiteng Zhao, who serve on our board of directors, as well as an executive officer for the - 176 -

year ended December 31, 2024, Bryan Ball. The following table presents the number of shares purchased and the total purchase price paid by these entities and individuals.

| Investor                           |     | Shares    
 Purchased |           |     | Warrants  
 Purchased |           |     | Total     
 Purchase  
 Price ($) |               |
| Entities affiliated with Avoro (1) |     |           |         0 |     |           | 8,333,000 |     |           | 19,998,